FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/29/2025
Back to search
Official data from USPTO
BIOSPRING
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079383378Class
1, 5, 40, 42, 44
Filing
79383378
Registration
7656488
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
04/03/2026
Trademark type
Combined
Nice classes
1, 5, 40, 42, 44
Filing date
06/27/2023
Registration date
01/21/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/21/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
DE
Examiner
FOSTER, ALEXANDRA M.
Law office
M80
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "BIOSPRING" in blue next to the stylized design of a double helix within a circle and surrounded by an incomplete circle, all in green. The white background is not claimed as a feature of the mark.
Holders and representatives
Holders
B. M. (pessoa física)
Representatives
Julie A. Katz Katz Group LLC
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Industrial chemicals; chemicals used in science; Nucleic acids for scientific purposes; Nucleotides for scientific and research useoligonucleotides
Class 5
Nucleic acid for medical diagnostic purposes; Oligonucleotides for medical diagnostic purposes; Oligonucleotides for pharmaceutical purposes; Pharmaceutical preparations for medical diagnostic purposes in the nature of diagnostic agents for medical use; chemical preparations for pharmaceutical purposes in the nature of diagnostic agents for medical use; Pharmaceutical preparations made of nucleic acids and nucleotidesin particular oligonucleotidesfor pharmaceutical purposes
Class 40
Distilling of chemicals for othersoligonucleotides; Custom manufacture of pharmaceuticals using oligonucleotides for third parties
Class 42
Scientific and technological servicesresearch and design in the field of nucleic acidsnucleotides and oligonucleotides; industrial analysis and industrial research of nucleic acidsnucleotides and oligonucleotides
Class 44
Analysis of nucleic acids and oligonucleotides for medical diagnostics and medical treatment
Publications
History of USPTO decisions and trademark events.
33 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
08/03/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
08/03/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/03/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/21/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/15/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/15/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/21/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/21/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/03/2024
PUBO
PUBLISHED FOR OPPOSITION
12/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/27/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/11/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
11/11/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/11/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
11/11/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/11/2024
DOCK
ASSIGNED TO EXAMINER
10/28/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/15/2024
GNFR
FINAL REFUSAL E-MAILED
05/15/2024
CNFR
FINAL REFUSAL WRITTEN
05/15/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/01/2024
RFNT
REFUSAL PROCESSED BY IB
04/30/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/09/2024
RFRR
REFUSAL PROCESSED BY MPU
04/09/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/14/2024
CNRT
NON-FINAL ACTION WRITTEN
03/13/2024
DOCK
ASSIGNED TO EXAMINER
03/13/2024
MAFR
APPLICATION FILING RECEIPT MAILED
11/21/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/17/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/16/2023
Continuous trademark protection
Get notified about every new filing that threatens BIOSPRING or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.